Alzheimer’s Disease: Current and Future Treatments. A Review
Journal: International Journal of Medical Students (IJMS) (Vol.2, No. 2)Publication Date: 2014-06-30
Authors : Evelyn Chou;
Page : 56-63
Keywords : Alzheimer’s disease; disease-modifying drugs; beta-secretase inhibitors; gamma-secretase inhibitors; cholinergic; amyloid; tau;
Abstract
Alzheimer’s disease (AD) is a currently incurable neurodegenerative disorder whose treatment poses a big challenge. Proposed causes of AD include the cholinergic, amyloid and tau hypotheses. Current therapeutic treatments have been aimed at dealing with the neurotransmitter imbalance. These include cholinesterase inhibitors and N-Methyl-D-aspartate (NMDA) antagonists. However, current therapeutics have been unable to halt AD progression. Much research has gone into the development of disease-modifying drugs to interfere with the course of the disease. Approaches include secretase inhibition and immunotherapy aimed at reducing plaque deposition. However, these have not been successful in curing AD as yet. It is believed that the main reason why therapeutics have failed to work is that treatment begins too late in the course of the disease. The future of AD treatment thus appears to lie with prevention rather than cure. In this article, current therapeutics and, from there, the future of AD treatment are discussed.
Other Latest Articles
- Awareness and Practices of Non-Pharmacological Approaches for Management of Hypertension in a Geriatric Population
- Sub-tenon Anaesthesia versus Intracameral Anaesthesia in Patients Undergoing Cataract Extraction: A Comparative Study of the Level of Pain, Visual Perception and Anxiety
- Attitude towards New Packaging to Reduce Condom-carrying Embarrassment among Thai Youth, A Cross-sectional Study
- Correlation of Fine Needle Aspiration Cytology and Histopathology Diagnosis in the Evaluation of Breast Lumps
- Poster Presentations: A Presenting Opportunity in Conferences for Medical Students
Last modified: 2014-12-09 02:33:33